Literature DB >> 5938817

Studies of PPLO infection. I. The production of cerebral polyarteritis by Mycoplasma gallisepticum in turkeys; the neurotoxic property of the Mycoplasma.

L Thomas, M Davidson, R T McCluskey.   

Abstract

Turkey poults injected intravenously with suspensions of Mycoplasma gallisepticum develop a fatal neurologic disease associated with polyarteritis affecting almost exclusively the cerebral arteries. The incubation period depends on the dose of organisms. With high doses (10(10) to 10(11) mycoplasmas) the birds become ill and die within a few hours; with lower doses (10(6) to 10(8)) neurologic manifestations appear after 7 days. The rapid onset of neurologic signs after high doses indicates the presence of a toxin in the mycoplasma, but efforts to extract toxin from disrupted organisms or to demonstrate its presence in culture fluid free of mycoplasmas have been unsuccessful. The toxin appears to be associated only with living mycoplasmas. The toxic component of M. gallisepticum is inactivated by heating the organisms at 50 degrees C, disruption by repeated cycles of freezing and thawing, and exposure to specific antibody. Treatment of turkeys with gold thiomalate furnishes partial protection against the toxic effects of large doses of mycoplasmas, and protection against the development of cerebral arteritis. Treatment with tetracycline protects completely against both toxicity and arteritis, and, when delayed, restores diseased birds to a healthy state. Cortisone, methotrexate and 6-mercaptopurine have no effect on the course or outcome of the disease. Intracerebral injections of M. gallisepticum are less toxic and lethal than when the same dose was given by vein, indicating that the organism exerts its damaging action on blood vessels by way of the blood stream. The arterial lesions resemble those of serum sickness, except for their distribution, and are associated with glomerular inflammatory lesions. However, for various reasons discussed, it is considered more likely that they result from a direct toxic action of living mycoplasmas on the vessels concerned than from an immunologic mechanism.

Entities:  

Mesh:

Year:  1966        PMID: 5938817      PMCID: PMC2138161          DOI: 10.1084/jem.123.5.897

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  INHIBITION OF IMMEDIATE AND DELAYED HYPERSENSITIVITY IN THE RABBIT BY 6-MERCAPTOPURINE.

Authors:  Y BOREL; R SCHWARTZ
Journal:  J Immunol       Date:  1964-05       Impact factor: 5.422

2.  A COMPARISON OF SOME CHARACTERISTICS OF MYCOPLASMA VAR. MYCOIDES AND MYCOPLASMA GALLISEPTICUM.

Authors:  H E ADLER
Journal:  Am J Vet Res       Date:  1964-01       Impact factor: 1.156

3.  GRANULOMATOUS ANGIITIS OF THE NERVOUS SYSTEM.

Authors:  G N BUDZILOVICH; I FEIGIN; H SIEGEL
Journal:  Arch Pathol       Date:  1963-09

4.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

Authors:  R M CHANOCK; L HAYFLICK; M F BARILE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-01-15       Impact factor: 11.205

5.  A new technique for the fluorescent labelling of proteins.

Authors:  H RINDERKNECHT
Journal:  Experientia       Date:  1960-09-15

6.  Pathology of PPLO and other agents in chicken embryos.

Authors:  H L CHUTE
Journal:  Ann N Y Acad Sci       Date:  1960-01-15       Impact factor: 5.691

7.  A preliminary report of efficiency of various mediums for isolation of pleuropneumonia-like organisms from exudates of birds with chronic respiratory disease.

Authors:  H E ADLER; R YAMAMOTO; R A BANKOWSKI
Journal:  Am J Vet Res       Date:  1954-07       Impact factor: 1.156

8.  The Curative Effect of Certain Gold Compounds on Experimental Proliferative, Chronic Arthritis in Mice.

Authors:  A B Sabin; J Warren
Journal:  J Bacteriol       Date:  1940-12       Impact factor: 3.490

9.  IDENTIFICATION OF THE FILTRABLE, TRANSMISSIBLE NEUROLYTIC AGENT ISOLATED FROM TOXOPLASMA-INFECTED TISSUE AS A NEW PLEUROPNEUMONIA-LIKE MICROBE.

Authors:  A B Sabin
Journal:  Science       Date:  1938-12-16       Impact factor: 47.728

10.  Sialic acid binding sites: role in hemagglutination by Mycoplasma gallisepticum.

Authors:  B Gesner; L Thomas
Journal:  Science       Date:  1966-02-04       Impact factor: 47.728

  10 in total
  26 in total

Review 1.  Post infectious CNS disorders: towards a unified approach.

Authors:  Marc Gotkine; Peter G E Kennedy; Israel Steiner
Journal:  J Neurol       Date:  2010-09-21       Impact factor: 4.849

Review 2.  The aetiology and pathogenesis of major systemic vasculitides.

Authors:  C O Savage; Y C Ng
Journal:  Postgrad Med J       Date:  1986-07       Impact factor: 2.401

3.  Vasculitis.

Authors:  M D Lockshin
Journal:  Bull N Y Acad Med       Date:  1979-10

4.  Pathogenesis of cardiac lesions in specific-pathogen-free chicken embryos infected with mycoplasma synoviae.

Authors:  K M Kerr; C H Bridges
Journal:  Am J Pathol       Date:  1970-06       Impact factor: 4.307

5.  [Clinical and pathological findings in a transmissible granulomatous meningoencephalomyelitis (gMEM) in domestic goats].

Authors:  E Dahme; D Stavrou; N Deutschländer; W Arnold; E Kaiser
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

6.  Mycoplasma gallisepticum infection in mice and cynomolgus monkeys. A histologic, immunofluorescence, and electron microscopic study of the heart.

Authors:  S C Sun; R S Sohal; K C Chu; H L Colcolough; E Leiderman; G E Burch
Journal:  Am J Pathol       Date:  1968-12       Impact factor: 4.307

7.  Central nervous system complications of Mycoplasma pneumoniae.

Authors:  G Decaux; M Szyper; M Ectors; A Cornil; L Franken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-10       Impact factor: 10.154

8.  Cerebral granulomatous angiitis with atypical features.

Authors:  W Kristoferitsch; K Jellinger; F Böck
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

9.  Tropism of Mycoplasma gallisepticum for arterial walls.

Authors:  W A Clyde; L Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

10.  [Factors influencing the susceptibility of mice to Mycoplasma arthritidis].

Authors:  B C Cole; J R Ward; L Golightly-Rowland
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.